AngioDynamics’ minimally invasive technologies specialize in the precise destruction of solid tumors – with the goal of expanding treatment options and improving the quality of life for patients diagnosed with cancer. AngioDynamics’ solutions aid in precise tumor targeting, minimally invasive therapies and supportive care – all with the goal of improving patient outcomes and quality of life in the fight against cancer.
AngioDynamics has initiated and completed numerous studies that help advance healthcare science in partnership with renowned medical professionals and organizations. Read more about clinical studies related to Oncology here.
The PRESERVE Study is complete, with results published on the NanoKnife System for prostate tissue ablation.
A Clinical Study That Evaluates the Effects of Irreversible Electroporation (IRE) Ablation Technology on the Treatment of Patients with Stage III Pancreatic Cancer
Get reimbursement assistance for AngioDynamics products and therapies.
Connect with us for service and sales.